Amidite monomer

US2025340585A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025340585-A1
Application numberUS-202218729747-A
CountryUS
Kind codeA1
Filing dateDec 22, 2022
Priority dateJan 21, 2022
Publication dateNov 6, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object is to provide an amidite monomer of diaminopurine and/or an amidite monomer of a thiouracil derivative suitable for use in synthesis of an acyclic single-stranded polynucleotide comprising diaminopurine and/or a thiouracil derivative by a phosphoramidite method. This object is achieved by an amidite monomer of diaminopurine and/or an amidite monomer of a thiouracil derivative protected with a specific protecting group removable by a base.

First claim

Opening claim text (preview).

1 . A compound or a salt thereof or a solvate thereof, the compound being represented by formula (1A) or (1B): wherein R 1 and R 2 are the same or different, and each is a hydrogen atom or an organic group; R 3 and R 4 are the same or different, and each is a protecting group for a hydroxyl group; R 5 and R 6 are the same or different, and each is an alkyl group; R 7 , R 8 , R 9 , and R 10 are the same or different, and each is a hydrogen atom or a protecting group removable by a base, excluding a case in which all are hydrogen atoms; and at least one protecting group removable by a base is a group represented by formula (a): wherein R a is a hydrogen atom or an alkyl group, and p is an integer of 1 to 3; R 11 is a hydrogen atom or an alkyl group; n is an integer of 1 to 3; and m is an integer of 0 to 3. 2 . The compound or a salt thereof or a solvate thereof according to claim 1 , wherein at least one of R 7 and R 8 is a group represented by formula (a), and at least one of R 9 and R 10 is a group represented by formula (a). 3 . The compound or a salt thereof or a solvate thereof according to claim 1 , wherein n is 1, m is 0, R a is a hydrogen atom, and p is 1. 4 . The compound or a salt thereof or a solvate thereof according to claim 1 , wherein R 3 is a group represented by formula (b): wherein R 31 , R 32 , and R 33 are the same or different, and each is a hydrogen atom or an alkoxy group, R 4 is —(CH 2 ) 2 —CN, and R 5 and R 6 are isopropyl groups. 5 . A reagent comprising the compound or a salt thereof or a solvate thereof according to claim 1 . 6 . The reagent according to claim 5 , which is a reagent for producing a polynucleotide. 7 . A method for producing a single-stranded polynucleotide by a phosphoramidite method, the method comprising using the compound or a salt thereof or a solvate thereof according to claim 1 as an amidite monomer.

Assignees

Inventors

Classifications

  • Processes for the preparation of sugar derivatives · CPC title

  • containing the ring system [IMAGE cpc-sch-C07F-1006.gif] having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs · CPC title

  • having the nitrogen atoms in positions 1 and 3 · CPC title

  • DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

  • Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025340585A1 cover?
An object is to provide an amidite monomer of diaminopurine and/or an amidite monomer of a thiouracil derivative suitable for use in synthesis of an acyclic single-stranded polynucleotide comprising diaminopurine and/or a thiouracil derivative by a phosphoramidite method. This object is achieved by an amidite monomer of diaminopurine and/or an amidite monomer of a thiouracil derivative protecte…
Who is the assignee on this patent?
National Univ Corporation Tokai National Higher Education And Research System
What technology area does this patent fall under?
Primary CPC classification C07F9/65616. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Nov 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).